GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020. The Quantum-Si ...

In the workflow of AmproCode, each type of the selected residues on peptide or protein samples can be respectively modified by the DNA barcode, and the composition code which is the relative ratio of ...

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...

Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...

Protein engineering is a powerful biotechnological process that focuses on creating new enzymes or proteins and improving the functions of existing ones by manipulating their natural macromolecular ...

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has ...

Protein barcodes are short, information- rich stretches of amino acids encoded by DNA sequences that can be added to the DNA sequences coding for proteins. Then, when protein barcode DNA and protein ...

Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...

Please provide your email address to receive an email when new articles are posted on . The patient had a clinically established eosinophilic esophagitis milk allergy. Conventional T cells that ...

Nucleic acid-based therapeutics, including antisense oligonucleotides (ASO), small interfering RNA (siRNA), messenger RNA (mRNA), immunomodulatory DNA/RNA, and gene-editing guide RNA (gRNA), hold ...